HF 2022: CLOROTIC: Combined Loop With Thiazide Diuretics in Pts With Decompensated HF | Dr Trullas

Подробнее о видео

Watch on Radcliffe Cardiology:

In this short interview, Dr Joan Carles Trullas (Universitat de Vic-Central de Catalunya, ES) outlines the findings of the CLOROTIC trial, first presented at Heart Failure 2022. In this study, patients with decompensated heart failure were given a combined diuretic therapy using loop diuretics with thiazide diuretics to evaluate efficacy.

Discussion Points:
1. Background
2. Patient Cohort and Study Design
3. Combined Diuretic Therapy
4. Key Findings
5. Conclusions
6. Further Research and Next Steps

Recorded at Heart Failure 2022, Madrid.
Videographers: Tom Green & Mike Knight
Interviewer: Mirjam Boros

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.